0001867096-23-000149.txt : 20231121
0001867096-23-000149.hdr.sgml : 20231121
20231121161658
ACCESSION NUMBER: 0001867096-23-000149
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231121
DATE AS OF CHANGE: 20231121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pieper Steven
CENTRAL INDEX KEY: 0001875714
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40880
FILM NUMBER: 231428326
MAIL ADDRESS:
STREET 1: XERIS PHARMACEUTICALS, INC.
STREET 2: 180 N. LASALLE STREET, SUITE 1600
CITY: CHICAGO
STATE: IL
ZIP: 60601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xeris Biopharma Holdings, Inc.
CENTRAL INDEX KEY: 0001867096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 871082097
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1375 WEST FULTON STREET, SUITE 1300
CITY: CHICAGO
STATE: IL
ZIP: 60607
BUSINESS PHONE: 844-445-5704
MAIL ADDRESS:
STREET 1: 1375 WEST FULTON STREET, SUITE 1300
CITY: CHICAGO
STATE: IL
ZIP: 60607
4
1
wk-form4_1700601408.xml
FORM 4
X0508
4
2023-11-20
0
0001867096
Xeris Biopharma Holdings, Inc.
XERS
0001875714
Pieper Steven
C/O XERIS BIOPHARMA HOLDINGS, INC.
1375 WEST FULTON STREET, SUITE 1300
CHICAGO
IL
60607
0
1
0
0
See Remarks
0
Common Stock
2023-11-20
4
P
0
28000
1.95
A
1176912
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $1.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Chief Financial Officer
/s/ Beth Hecht, as Attorney-in-Fact
2023-11-21